- Home
- ZTS
ZTS
Zoetis Inc.
as of 07-27-2026 2:56pm EST
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
| Founded: | 1952 | Country: | United States |
| Employees: | N/A | City: | PARSIPPANY |
| Market Cap: | 31.9B | IPO Year: | 2012 |
| Target Price: | $154.18 | AVG Volume (30 days): | 4.6M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | semi-annual | |
| EPS: | 1.42 | EPS Growth: | 10.05 |
| 52 Week Low/High: | $71.47 - $160.48 | Next Earning Date: | 05-07-2026 |
| Revenue: | $9,467,000,000 | Revenue Growth: | 2.28% |
| Revenue Growth (this year): | 5.63% | Revenue Growth (next year): | 4.77% |
| P/E Ratio: | 53.09 | Index: | |
| Free Cash Flow: | 2.3B | FCF Growth: | -0.65% |
AI-Powered ZTS Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Zoetis Inc. (ZTS)
Director
Avg Cost/Share
$75.88
Shares
2,000
Total Value
$151,750.00
Owned After
27,862
SEC Form 4
Director
Avg Cost/Share
$75.39
Shares
6,650
Total Value
$501,343.50
Owned After
21,458
SEC Form 4
Director
Avg Cost/Share
$77.76
Shares
3,000
Total Value
$233,273.40
Owned After
24,524
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BISARO PAUL | ZTS | Director | May 13, 2026 | Buy | $75.88 | 2,000 | $151,750.00 | 27,862 | |
| DAMELIO FRANK A | ZTS | Director | May 13, 2026 | Buy | $75.39 | 6,650 | $501,343.50 | 21,458 | |
| MCCALLISTER MICHAEL B | ZTS | Director | May 11, 2026 | Buy | $77.76 | 3,000 | $233,273.40 | 24,524 |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q1 Q1 2026 Earnings
8-K SELL May 7, 2026 · 100% conf.
Q1 2026 Earnings
8-K SELLMay 7, 2026 · 100% conf.
1D
-1.30%
$86.17
Act: -5.06%
5D
-2.13%
$85.45
Act: -13.55%
20D
-3.80%
$84.00
Act: -8.96%
EX-99.1
2 exhibit99q12026.htm
EX-99.1
Document
EXHIBIT 99.1
Zoetis Announces First Quarter 2026 Results
•Revenue of $2.3 Billion, Growing 3%, and Net Income of $601 Million, or $1.42 per Diluted Share, Flat and Increasing 6%, Respectively, on a Reported Basis
•Adjusted Net Income of $646 Million, or Adjusted Diluted EPS of $1.53
•Flat Organic Operational Growth in Revenue and 1% Organic Operational Growth in Adjusted Net Income
•Revises Full Year 2026 Revenue Guidance to $9.680 - $9.960 Billion with Organic Operational Revenue Growth of 2% to 5%
•Revises Full Year 2026 Guidance for Organic Operational Growth in Adjusted Net Income to 2% to 6%
•Revises Guidance for Diluted EPS on an Adjusted Basis to $6.85 to $7.00
PARSIPPANY, N.J. – May 7, 2026 – Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today reported its financial results for the first quarter of 2026.
The company reported revenue of $2.3 billion for the first quarter of 2026, an increase of 3% compared with the first quarter of 2025 and flat on an organic operational1 basis. Net income for the first quarter of 2026 was $601 million, or $1.42 per diluted share, reflecting flat performance and growth of 6%, respectively, on a reported basis.
Adjusted net income2 for the first quarter of 2026 was $646 million, or $1.53 per diluted share, an increase of 2% and 9%, respectively, on a reported basis, and an increase of 1% and 7%, respectively, on an organic operational basis. Adjusted net income for the first quarter of 2026 excludes the net impact of $45 million for purchase accounting adjustments, acquisition and divestiture-related costs and certain significant items.
“The first quarter unfolded in a more challenging operating environment than we anticipated. Pet owners demonstrated increased price sensitivity, resulting in a decline in veterinary visits and softer demand for premium innovative products, where Zoetis leads. At the same time, competition intensified across key pet care categories, including dermatology and parasiticides. We are taking decisive action to sharpen commercial execution, unlock revenue and continue to drive disciplined cost management. The breadth of our portfolio remains a strength, reflected in the performance of International, livestock, and diagnostics in the quarter,” said Kristin Peck, Chief Executive Officer of Zoetis. “With a robust pipeline of more than 12 potential blockbusters, a proven science-to-scale model that has consistently
1 |
enabled us to compete and win, and a resilient, diversified business supported by strong industry fundamentals, we are well positioned to deliver our next wave of innovation and remain confident in our ability to deliver sustained value for shareholders."
SEGMENT HIGHLIGHTS
Zoetis organizes and manages its commercial operations across two segments: United States (U.S.) and International. Within these segments, the company delivers a diverse portfolio of products for companion animals and livestock, tailored to local trends and customer needs. In the first quarter of 2026:
•Revenue in the U.S. segment was $1.1 billion, reflecting a decrease of 8% on both a reported and an organic operational basis relative to the first quarter of 2025. Companion animal product sales decreased 11% due to softer end-market demand and an increasingly competitive landscape. The company's key dermatology franchise and Simparica Trio® faced heightened competitive pressure and persistent macroeconomic-driven price sensitivity. Also contributing to the decline was the impact of generic competition on the Convenia® and Cerenia® brands, as well as lower sales of Librela®, the company's monoclonal antibody (mAb) product for osteoarthritis (OA) pain. Sales of livestock products increased 7% on both a reported and organic operational basis in the quarter, supported by broad-based strength across cattle, poultry and swine. Cattle performance was driven primarily by favorable producer economics in beef cattle, supply timing and expanded targeted use of parasiticides in response to New World screwworm. Poultry performance benefited from increased vaccine sales tied to disease outbreak activity, while swine growth reflected improved supply for a key antibiotic product.
•Revenue in the International segment was $1.1 billion, a 17% increase on a reported basis and a 10% increase on an organic operational basis compared with the first quarter of 2025. Companion animal product sales grew 15% on a reported basis and 7% on an organic operational basis, led by the company's parasiticides portfolio, including Simparica Trio, along with contributions from diagnostics, vaccines, and the timing of price increases. These gains were partially offset by lower sales of key dermatology products, driven primarily by competitive dynamics. Sales of livestock products grew 19% on a reported basis and 14% on an organic operational basis, driven by broad-based growth across all core species including
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 12, 2026 · 100% conf.
Q4 2025 Earnings
8-K BUYFeb 12, 2026 · 100% conf.
1D
+1.38%
$127.37
Act: +0.80%
5D
+3.29%
$129.78
Act: +2.50%
20D
+4.58%
$131.39
Act: -7.79%
zts-202602120001555280false00015552802026-02-122026-02-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 12, 2026
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On February 12, 2026, Zoetis Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and full year 2025 and providing its guidance for full year 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits 99.1 Press Release of Zoetis Inc. dated February 12, 2026, reporting Zoetis' financial results for the fourth quarter and full year 2025 and providing its guidance for full year 2026
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Zoetis Inc.
February 12, 2026 By:/s/ WETTENY JOSEPH
Wetteny Joseph Executive Vice President and Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 4, 2025
Q3 2025 Earnings
8-KNov 4, 2025
zts-202511040001555280false00015552802025-11-042025-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 4, 2025
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On November 4, 2025, Zoetis Inc. (the Company) issued a press release reporting its financial results for the third quarter of 2025 and its guidance for full year 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated November 4, 2025, reporting Zoetis' financial results for the
third quarter of 2025 and its guidance for full year 2025.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
November 4, 2025 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 5, 2025
Q2 2025 Earnings
8-KAug 5, 2025
zts-202508050001555280false00015552802025-08-052025-08-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 5, 2025
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On August 5, 2025, Zoetis Inc. (the Company) issued a press release reporting its financial results for the second quarter of 2025 and its guidance for full year 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated August 5, 2025, reporting Zoetis' financial results for the
second quarter of 2025 and its guidance for full year 2025.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
August 5, 2025 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2025 Q1 Q1 2025 Earnings
8-K May 6, 2025
Q1 2025 Earnings
8-KMay 6, 2025
zts-202505060001555280false00015552802025-05-062025-05-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 6, 2025
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On May 6, 2025, Zoetis Inc. (the Company) issued a press release reporting its financial results for the first quarter of 2025 and its guidance for full year 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated May 6, 2025, reporting Zoetis' financial results for the
first quarter of 2025 and its guidance for full year 2025.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
May 6, 2025 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2024 Q4 Q4 2024 Earnings
8-K Feb 13, 2025
Q4 2024 Earnings
8-KFeb 13, 2025
zts-202502130001555280false00015552802024-02-132024-02-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 13, 2025
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On February 13, 2025, Zoetis Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and full year 2024 and providing its guidance for full year 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits 99.1 Press Release of Zoetis Inc. dated February 13, 2025, reporting Zoetis' financial results for the fourth quarter and full year 2024 and providing its guidance for full year 2025
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Zoetis Inc.
February 13, 2025 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2024 Q3 Q3 2024 Earnings
8-K Nov 4, 2024
Q3 2024 Earnings
8-KNov 4, 2024
zts-202411040001555280false00015552802024-11-042024-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 4, 2024
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On November 4, 2024, Zoetis Inc. (the Company) issued a press release reporting its financial results for the third quarter of 2024 and raising and updating its guidance for full year 2024. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated November 4, 2024, reporting Zoetis' financial results for the
third quarter of 2024 and raising and updating its guidance for full year 2024.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
November 4, 2024 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2024 Q2 Q2 2024 Earnings
8-K Aug 6, 2024
Q2 2024 Earnings
8-KAug 6, 2024
zts-202408060001555280false00015552802024-08-062024-08-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 6, 2024
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On August 6, 2024, Zoetis Inc. (the Company) issued a press release reporting its financial results for the second quarter of 2024 and raising its guidance for full year 2024. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated August 6, 2024, reporting Zoetis' financial results for the
second quarter of 2024 and raising its guidance for full year 2024.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
August 6, 2024 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2024 Q1 Q1 2024 Earnings
8-K May 2, 2024
Q1 2024 Earnings
8-KMay 2, 2024
zts-202405020001555280false00015552802024-05-022024-05-02
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 2, 2024
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On May 2, 2024, Zoetis Inc. (the Company) issued a press release reporting its financial results for the first quarter of 2024 and updating its guidance for full year 2024. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated May 2, 2024, reporting Zoetis' financial results for the
first quarter of 2024 and updating its guidance for full year 2024.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
May 2, 2024 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2023 Q4 Q4 2023 Earnings
8-K Feb 13, 2024
Q4 2023 Earnings
8-KFeb 13, 2024
zts-202402130001555280false00015552802024-02-132024-02-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 13, 2024
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On February 13, 2024, Zoetis Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and full year 2023 and providing its guidance for full year 2024. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits 99.1 Press Release of Zoetis Inc. dated February 13, 2024, reporting Zoetis' financial results for the fourth quarter and full year 2023 and providing its guidance for full year 2024
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Zoetis Inc.
February 13, 2024 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2023 Q3 Q3 2023 Earnings
8-K Nov 2, 2023
Q3 2023 Earnings
8-KNov 2, 2023
zts-202311020001555280false00015552802023-11-022023-11-02
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 2, 2023
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On November 2, 2023, Zoetis Inc. (the Company) issued a press release reporting its financial results for the third quarter of 2023 and updated its guidance for full year 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated November 2, 2023, reporting Zoetis' financial results for the
third quarter of 2023 and updated its guidance for full year 2023.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
November 2, 2023 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2023 Q2 Q2 2023 Earnings
8-K Aug 8, 2023
Q2 2023 Earnings
8-KAug 8, 2023
zts-202308080001555280false00015552802023-08-082023-08-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 8, 2023
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On August 8, 2023, Zoetis Inc. (the Company) issued a press release reporting its financial results for the second quarter of 2023 and updating its guidance for full year 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated August 8, 2023, reporting Zoetis' financial results for the
second quarter of 2023 and updating its guidance for full year 2023.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
August 8, 2023 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2023 Q1 Q1 2023 Earnings
8-K May 4, 2023
Q1 2023 Earnings
8-KMay 4, 2023
zts-202305040001555280false00015552802023-05-042023-05-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 4, 2023
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On May 4, 2023, Zoetis Inc. (the Company) issued a press release reporting its financial results for the first quarter of 2023 and maintaining its guidance for full year 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated May 4, 2023, reporting Zoetis' financial results for the
first quarter of 2023 and maintaining its guidance for full year 2023.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
May 4, 2023 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2022 Q4 Q4 2022 Earnings
8-K Feb 14, 2023
Q4 2022 Earnings
8-KFeb 14, 2023
zts-202302140001555280false00015552802023-02-142023-02-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 14, 2023
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On February 14, 2023, Zoetis Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and full year 2022 and providing its guidance for full year 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits 99.1 Press Release of Zoetis Inc. dated February 14, 2023, reporting Zoetis' financial results for the fourth quarter and full year 2022 and providing its guidance for full year 2023
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Zoetis Inc.
February 14, 2023 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2022 Q3 Q3 2022 Earnings
8-K Nov 3, 2022
Q3 2022 Earnings
8-KNov 3, 2022
zts-202211030001555280false00015552802022-11-032022-11-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 3, 2022
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On November 3, 2022, Zoetis Inc. (the Company) issued a press release reporting its financial results for the third quarter of 2022 and updating its guidance for full year 2022. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated November 3, 2022, reporting Zoetis' financial results for the
third quarter of 2022 and lowering its guidance for full year 2022.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
November 3, 2022 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2022 Q2 Q2 2022 Earnings
8-K Aug 4, 2022
Q2 2022 Earnings
8-KAug 4, 2022
zts-202208040001555280false00015552802022-08-042022-08-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 4, 2022
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On August 4, 2022, Zoetis Inc. (the Company) issued a press release reporting its financial results for the second quarter of 2022 and updating its guidance for full year 2022. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated August 4, 2022, reporting Zoetis' financial results for the
second quarter of 2022 and updating its guidance for full year 2022.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
August 4, 2022 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2022 Q1 Q1 2022 Earnings
8-K May 5, 2022
Q1 2022 Earnings
8-KMay 5, 2022
zts-202205050001555280false00015552802022-05-052022-05-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 5, 2022
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On May 5, 2022, Zoetis Inc. (the Company) issued a press release reporting its financial results for the first quarter of 2022 and updating its guidance for full year 2022. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated May 5, 2022, reporting Zoetis' financial results for the
first quarter of 2022 and updating its guidance for full year 2022.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
May 5, 2022 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2021 Q4 Q4 2021 Earnings
8-K Feb 15, 2022
Q4 2021 Earnings
8-KFeb 15, 2022
zts-202202150001555280false00015552802022-02-152022-02-15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 15, 2022
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On February 15, 2022, Zoetis Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and full year 2021 and providing its guidance for full year 2022. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits 99.1 Press Release of Zoetis Inc. dated February 15, 2022, reporting Zoetis' financial results for the fourth quarter and full year 2021 and providing its guidance for full year 2022
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Zoetis Inc.
February 15, 2022 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President and Chief Financial Officer
2021 Q3 Q3 2021 Earnings
8-K Nov 4, 2021
Q3 2021 Earnings
8-KNov 4, 2021
zts-202111040001555280false00015552802021-11-042021-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 4, 2021
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On November 4, 2021, Zoetis Inc. (the Company) issued a press release reporting its financial results for the third quarter of 2021 and increasing its guidance for full year 2021. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated November 4, 2021, reporting Zoetis' financial results for the
third quarter of 2021 and increasing its guidance for full year 2021.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
November 4, 2021 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President, Chief Financial Officer and Head of Business Development
2021 Q2 Q2 2021 Earnings
8-K Aug 5, 2021
Q2 2021 Earnings
8-KAug 5, 2021
zts-202108050001555280false00015552802021-08-052021-08-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 5, 2021
Zoetis Inc. (Exact name of registrant as specified in its charter)
Delaware001-3579746-0696167 (State or other jurisdiction(Commission File(I.R.S. Employer of incorporation)Number)Identification No.)
10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices)(Zip Code)
(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable (Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareZTSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On August 5, 2021, Zoetis Inc. (the Company) issued a press release reporting its financial results for the second quarter of 2021 and increasing its guidance for full year 2021. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No.Description
99.1 Press Release of Zoetis Inc. dated August 5, 2021, reporting Zoetis' financial results for the
second quarter of 2021 and increasing its guidance for full year 2021.
EX-101.INSInline XBRL INSTANCE DOCUMENT
EX-101.SCHInline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CALInline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LABInline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PREInline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEFInline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
Zoetis Inc.
August 5, 2021 By:/S/ WETTENY JOSEPH Wetteny Joseph Executive Vice President, Chief Financial Officer and Head of Business Development
Compare ZTS vs Leading Stocks
See how ZTS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ZTS Zoetis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.